Federated Hermes, Inc.

Equities

FHI

US3142111034

Investment Management & Fund Operators

Real-time Estimate Cboe BZX Other stock markets 11:46:49 05/07/2024 pm IST			5-day change	1st Jan Change
32.57 ^USD	-1.15%		-0.91%	-3.78%

04/06	AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders.	CI
03/06	After trial, investors weigh Trump 2.0 factor as election looms	RE

Tranche Update on Federated Investors, Inc.'s Equity Buyback Plan announced on February 19, 2015.

January 27, 2017 at 09:45 pm IST

From October 1, 2016 to December 31, 2016, the company has repurchased 606,916 shares, representing 0.61% for $16.66 million. With this, the company has completed the repurchase of 4,000,000 shares, representing 4.01% for $113.84 million under the buyback announced on February 19, 2015.

Latest news about Federated Hermes, Inc.

AstraZeneca AB completed the acquisition of Fusion Pharmaceuticals Inc. from a group of shareholders.	04/06	CI
After trial, investors weigh Trump 2.0 factor as election looms	03/06	RE
Zenas BioPharma, Inc. announced that it has received $200.145732 million in funding from a group of investors	07/05	CI
Zenas BioPharma, Inc. announced that it expects to receive $200.145732 million in funding	03/05	CI
RBC Capital Cuts Federated Hermes Price Target to $35 From $37, Maintains Sector Perform Rating	29/04	MT
UBS Adjusts Federated Hermes Price Target to $36 From $39, Maintains Neutral Rating	29/04	MT
Transcript : Federated Hermes, Inc., Q1 2024 Earnings Call, Apr 26, 2024	26/04
Tranche Update on Federated Hermes, Inc.'s Equity Buyback Plan announced on October 26, 2023.	26/04	CI
Federated Hermes, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	26/04	CI
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 EPS $0.89	26/04	MT
Earnings Flash (FHI) FEDERATED HERMES Posts Q1 Revenue $396.4M	26/04	MT
Federated Hermes, Inc. Declares Special Dividend, Payable on May 15, 2024	26/04	CI
Federated Hermes, Inc. Declares Quarterly Dividend, Payable on May 15, 2024	26/04	CI
Transcript : Federated Hermes, Inc. - Shareholder/Analyst Call	26/04
UBS Adjusts Federated Hermes Price Target to $39 From $37, Maintains Neutral Rating	12/04	MT
EMEA Morning Briefing : Stocks Seen Lower; Investors Await Fresh Data for Rate Cut Cues	26/03	DJ
EMEA Morning Briefing : Stocks May Ease After Record Highs	22/03	DJ
Policy uncertainty drives investors into US medium-term bond funds	20/03	RE
AstraZeneca AB entered into a definitive agreement to acquire Fusion Pharmaceuticals Inc. for $1.8 billion.	19/03	CI
Regulus Therapeutics Inc. announced that it has received $100.000267 million in funding from a group of investors	14/03	CI
Analysis-Property titans seek clues in Cannes for market turnaround	13/03	RE
Federated Hermes Premier Municipal Income Fund Declares Dividend, Payable on April 1, 2024	11/03	CI
Regulus Therapeutics Inc. announced that it expects to receive $100.000267 million in funding from a group of investors	11/03	CI
Federated Hermes Insider Sold Shares Worth $500,327, According to a Recent SEC Filing	08/03	MT
Xcelerate Pte Ltd announced that it has received $25 million in funding from Federated Hermes, Inc., Altair Capital Advisors Pte Ltd, Exacta Capital Partners, and other investors	25/02	CI

Chart Federated Hermes, Inc.

Duration

Period

More charts

Company Profile

Federated Hermes, Inc. is an investment management company. The Company operates through a single segment, being the investment management business. It sponsors, markets and provides investment-related services to various investment products, including sponsored investment companies and other funds (Federated Hermes Funds); and Separate Accounts, which include separately managed accounts (SMAs), institutional accounts, sub-advised funds and other managed products in both domestic and international markets. In addition, it markets and provides stewardship and real estate development services to various domestic and international companies. The Company provides investment advisory services to approximately 180 Federated Hermes Funds. It markets these funds to institutional customers and banks, broker/dealers and other financial intermediaries who use them to meet the needs of customers and/or clients, including, among others, retail investors, corporations and retirement plans.

Sector

Investment Management & Fund Operators

Calendar

25/07/2024 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

INTERVIEW - Linda Duessel, Federated Hermes: US-China tension around AI makes investing in China riskier

September 12, 2023 at 02:18 am IST

More Strategies

Ratings for Federated Hermes, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

32.95 USD

Average target price

37.12 USD

Spread / Average Target

+12.67%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Investment Management

	1st Jan change	Capi.
FEDERATED HERMES, INC.	-3.78%	2.64B
KKR & CO. INC.	+27.65%	94.12B
BLACKSTONE INC.	-6.13%	93.68B
ARES MANAGEMENT CORPORATION	+15.55%	27.56B
LEGAL & GENERAL PLC	-7.49%	17.6B
THE CARLYLE GROUP INC.	-0.74%	14.61B
AMUNDI	+4.38%	14.16B
FRANKLIN RESOURCES, INC.	-26.10%	11.81B
HDFC ASSET MANAGEMENT COMPANY LIMITED	+32.13%	10.8B
BLUE OWL CAPITAL INC.	+18.62%	9.21B

Investment Management